tiprankstipranks
Trending News
More News >
Conmed (CNMD)
NYSE:CNMD
US Market
Advertisement

Conmed (CNMD) Technical Analysis

Compare
197 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Conmed’s (CNMD) Moving Averages Convergence Divergence (MACD) indicator is -1.63, suggesting Conmed is a Buy.
Conmed’s (CNMD) 20-Day exponential moving average is 49.19, while Conmed’s (CNMD) share price is $48.13, making it a Sell.
Conmed’s (CNMD) 50-Day exponential moving average is 51.02, while Conmed’s (CNMD) share price is $48.13, making it a Sell.

Conmed (CNMD) Pivot Points

Oct 07, 2025, 03:08 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
44.23
45.03
45.82
46.62
47.41
48.21
49.00
Fibonacci
45.03
45.64
46.02
46.62
47.23
47.61
48.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Conmed (CNMD) Moving Averages

Oct 07, 2025, 03:08 AM
Period
Simple
Exponential
MA5
46.92Buy
47.30Buy
MA10
47.36Buy
47.82Buy
MA20
49.83Sell
49.19Sell
MA50
51.74Sell
51.02Sell
MA100
52.85Sell
52.86Sell
MA200
57.09Sell
57.51Sell
Conmed’s (CNMD) 10-Day exponential moving average is 47.82, while Conmed’s (CNMD) share price is $48.13, making it a Buy.
Conmed’s (CNMD) 100-Day exponential moving average is 52.86, while Conmed’s (CNMD) share price is $48.13, making it a Sell.
Conmed’s (CNMD) stock price is $48.13 and Conmed’s (CNMD) 50-day simple moving average is 51.74, creating a Sell signal.
Conmed’s (CNMD) stock price is $48.13 and Conmed’s (CNMD) 100-day simple moving average is 52.85, creating a Sell signal.
Conmed’s (CNMD) stock price is $48.13 and Conmed’s (CNMD) 200-day simple moving average is 57.09, creating a Sell signal.

Conmed (CNMD) Technical Indicators

Oct 07, 2025, 03:08 AM
Name
Value
Implied Action
RSI (14)
43.08
Neutral
STOCH (9,6)
38.81
Neutral
STOCHRSI (14)
25.93
Neutral
MACD (12,26)
-1.63
Buy
ADX (14)
27.88
Neutral
Williams %R
-64.00
Buy
CCI (14)
-56.45
Neutral
ATR (14)
1.72
-
Ultimate Oscillator
51.51
Neutral
ROC
-7.07
Sell
Conmed’s (CNMD) Relative Strength Index (RSI) is 43.08, creating a Neutral signal.
Conmed’s (CNMD) Trend Strength Indicator (ADX) is 27.88, creating a Neutral signal.
Conmed’s (CNMD) Commodity Channel Index (CCI) is -56.45, creating a Neutral signal.
Conmed’s (CNMD) Price Rate of Change (ROC) is -7.07, creating a Sell signal.

FAQ

Is CNMD a Buy, Hold, or Sell?
Based on CNMD’s technical indicators, CNMD is a Sell.
    What is CNMD’s RSI (14)?
    CNMD’s RSI (14) is 43.08, which suggests CNMD is a Neutral.
      What is CNMD’s MACD?
      CNMD’s MACD is -1.63, which suggests CNMD is a Buy.
        What is CNMD’s 5-day moving average?
        CNMD’s 5-day moving average is 46.92, which suggests CNMD is a Buy.
          What is CNMD’s 20-day moving average?
          CNMD 20-day moving average is 49.83, which suggests CNMD is a Sell.
            What is CNMD’s 50-day moving average?
            CNMD’s 50-day moving average is 51.74, which suggests CNMD is a Sell.
              What is CNMD’s 200-day moving average?
              CNMD’s 200-day moving average is 57.09, which suggests CNMD is a Sell.
                What is CNMD’s Williams % R (14)?
                CNMD’s Williams % R (14) is -64.00, which suggests CNMD is a Buy.
                  What is CNMD’s CCI (14)?
                  CNMD’s CCI (14) is -56.45, which suggests CNMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis